Acknowledgement
Supported by : Korean Society of Cardiology
References
- Kirtane AJ, Gupta A, Iyengar S, et al. Safety and efficacy of drugeluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation 2009;119:3198-206. https://doi.org/10.1161/CIRCULATIONAHA.108.826479
- Kamath KR, Barry JJ, Miller KM. The Taxus drug-eluting stent: a new paradigm in controlled drug delivery. Adv Drug Deliv Rev 2006;58:412-36. https://doi.org/10.1016/j.addr.2006.01.023
- Kee WJ, Jeong MH, Jang SY, et al. Very late stent thrombosis due to neointimal rupture after paclitaxel-eluting stent implantation. Korean Circ J 2011;41:754-8. https://doi.org/10.4070/kcj.2011.41.12.754
- Herdeg C, Oberhoff M, Baumbach A, et al. Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo. J Am Coll Cardiol 2000;35:1969-76. https://doi.org/10.1016/S0735-1097(00)00614-8
- Albrecht T, Speck U, Baier C, Wolf KJ, Bohm M, Scheller B. Reduction of stenosis due to intimal hyperplasia after stent supported angioplasty of peripheral arteries by local administration of paclitaxel in swine. Invest Radiol 2007;42:579-85. https://doi.org/10.1097/RLI.0b013e31804f5a60
- Regar E, Sianos G, Serruys PW. Stent development and local drug delivery. Br Med Bull 2001;59:227-48. https://doi.org/10.1093/bmb/59.1.227
- McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drugeluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364:1519-21. https://doi.org/10.1016/S0140-6736(04)17275-9
- Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimusand paclitaxel-eluting coronary stents. N Engl J Med 2007;356:998-1008. https://doi.org/10.1056/NEJMoa067193
- Nebeker JR, Virmani R, Bennett CL, et al. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol 2006;47:175-81. https://doi.org/10.1016/j.jacc.2005.07.071
- Otsuka Y, Chronos NA, Apkarian RP, Robinson KA. Scanning electron microscopic analysis of defects in polymer coatings of three commercially available stents: comparison of BiodivYsio, Taxus and Cypher stents. J Invasive Cardiol 2007;19:71-6.
- Nakazawa G, Vorpahl M, Finn AV, Narula J, Virmani R. One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis. JACC Cardiovasc Imaging 2009;2:625-8. https://doi.org/10.1016/j.jcmg.2009.01.011
- Goueffic Y, Guilluy C, Guerin P, Patra P, Pacaud P, Loirand G. Hyaluronan induces vascular smooth muscle cell migration through RHAMM-mediated PI3K-dependent Rac activation. Cardiovasc Res 2006;72:339-48. https://doi.org/10.1016/j.cardiores.2006.07.017
- Barbucci R, Lamponi S, Magnani A, et al. Influence of Sulfation on Platelet Aggregation and Activation with Differentially Sulfated Hyaluronic Acids. J Thromb Thrombolysis 1998;6:109-15. https://doi.org/10.1023/A:1008841303634
- Buszman P, Trznadel S, Zurakowski A, et al. Prospective registry evaluating safety and efficacy of cobalt-chromium stent implantation in patients with de novo coronary lesions. Kardiol Pol 2007;65:1041-6; discussion 1047-8.
- Bae IH, Lim KS, Park JK, et al. Mechanical behavior and in vivo properties of newly designed bare metal stent for enhanced flexibility. J Indst Eng Chem 2015;21:1295-300. https://doi.org/10.1016/j.jiec.2014.05.045
- Ding D, Tang X, Cao X, et al. Novel self-assembly endows human serum albumin nanoparticles with an enhanced antitumor efficacy. AAPS Pharm Sci Tech 2014;15:213-22. https://doi.org/10.1208/s12249-013-0041-3
- Che HL, Bae IH, Lim KS, et al. Novel fabrication of microRNA nanoparticle-coated coronary stent for prevention of postangioplasty restenosis. Korean Circ J 2016;46:23-32. https://doi.org/10.4070/kcj.2016.46.1.23
- Qian Z, Haessler M, Lemos JA, et al. Targeting vascular injury using Hantavirus-pseudotyped lentiviral vectors. Mol Ther 2006;13:694-704. https://doi.org/10.1016/j.ymthe.2005.11.016
- Schwartz RS, Edelman E, Virmani R, et al. Drug-eluting stents in preclinical studies: updated consensus recommendations for preclinical evaluation. Circ Cardiovasc Interv 2008;1:143-53. https://doi.org/10.1161/CIRCINTERVENTIONS.108.789974
- Kolodgie FD, John M, Khurana C, et al, Sustained reduction of instent neointimal growth with the use of a novel systemic nanoparticle paclitaxel. Circulation 2002;106:1195-8. https://doi.org/10.1161/01.CIR.0000032141.31476.15
- Rodrigues SN, Goncalves IC, Martins MC, Barbosa MA, Ratner BD. Fibrinogen adsorption, platelet adhesion and activation on mixed hydroxyl-/methyl-terminated self-assembled monolayers. Biomaterials 2006;27:5357-67. https://doi.org/10.1016/j.biomaterials.2006.06.010
- Jabara R, Chronos N, Conway D, Molema W, Robinson K. Evaluation of a novel slow-release paclitaxel-eluting stent with a bioabsorbable polymeric surface coating. JACC Cardiovasc Interv 2008;1:81-7. https://doi.org/10.1016/j.jcin.2007.11.009
- Seidel CL. Cellular heterogeneity of the vascular tunica media. Implications for vessel wall repair. Arterioscler Thromb Vasc Biol 1997;17:1868-71. https://doi.org/10.1161/01.ATV.17.10.1868
- Waugh J, Wagstaff AJ. The paclitaxel (TAXUS)-eluting stent: a review of its use in the management of de novo coronary artery lesions. Am J Cardiovasc Drugs 2004;4:257-68. https://doi.org/10.2165/00129784-200404040-00006
- Popma JJ, Califf RM, Topol EJ. Clinical trials of restenosis after coronary angioplasty. Circulation 1991;84:1426-36. https://doi.org/10.1161/01.CIR.84.3.1426
- Clowes AW, Clowes MM, Kinetics of cellular proliferation after arterial injury. II. Inhibition of smooth muscle growth by heparin. Lab Invest 1985;52:611-6.
- Baek S, March KL, Gene therapy for restenosis: getting nearer the heart of the matter. Circ Res 1998;82:295-305. https://doi.org/10.1161/01.RES.82.3.295
- Park S, Bhang SH, La WG, Seo J, Kim BS, Char K. Dual roles of hyaluronic acids in multilayer films capturing nanocarriers for drugeluting coatings. Biomaterials 2012;33:5468-77. https://doi.org/10.1016/j.biomaterials.2012.04.005
- Ceonzo K, Gaynor A, Shaffer L, Kojima K, Vacanti CA, Stahl GL. Polyglycolic acid-induced inflammation: role of hydrolysis and resulting complement activation. Tissue Eng 2006;12:301-8. https://doi.org/10.1089/ten.2006.12.301
- Commandeur S, van Beusekom HM, van der Giessen WJ. Polymers, drug release, and drug-eluting stents. J Interv Cardiol 2006;19:500-6. https://doi.org/10.1111/j.1540-8183.2006.00198.x
- Bangalore S, Toklu B, Amoroso N, et al. Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis. BMJ 2013;347:f6625. https://doi.org/10.1136/bmj.f6625
- Meng S, Liu Z, Shen L, et al. The effect of a layer-by-layer chitosanheparin coating on the endothelialization and coagulation properties of a coronary stent system. Biomaterials 2009;30:2276-83. https://doi.org/10.1016/j.biomaterials.2008.12.075
Cited by
- Novel Polymer-Free Everolimus-Eluting Stent Fabricated using Femtosecond Laser Improves Re-endothelialization and Anti-inflammation vol.8, pp.None, 2017, https://doi.org/10.1038/s41598-018-25629-9
- Fabrication and Evaluation of Polyelectrolyte Complexes of Dextran Derivatives for Drug Coating of Coronary Stents vol.30, pp.5, 2017, https://doi.org/10.14478/ace.2019.1057